Global pharma company Jazz Pharmaceuticals has reached an agreement to buy U.K.-based GW Pharmaceuticals, one of the largest medical cannabinoid businesses in the world, for $7.2 billion in cash and stock, the drugmakers announced Wednesday.
Medical ca…
GW Pharmaceuticals
GW Pharma expects fiscal 2020 sales to reach $526 million
United Kingdom-based GW Pharmaceuticals expects to report annual sales of approximately $526 million for the year ended Dec. 31, 2020, it said in a preview of its fourth quarter and full-year results. Fourth quarter net sales will be approximately $148…
Denmark medical cannabis sales post a positive quarter thanks to Epidiolex
Sales of medical marijuana in Denmark posted healthy gains in the third quarter of 2020, coinciding with the launch of GW Pharmaceuticals’ cannabis drug Epidiolex. Overall sales of all medial cannabis products grew from about 13 million Danish Kr…
Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement
Canadian cannabis producer Canopy Growth Corp. is suing Britain’s GW Pharmaceuticals in U.S. federal court, alleging that GW is knowingly infringing upon Canopy’s intellectual property. GW uses a Canopy-patented method to extract the CBD th…
Epidiolex maker GW reports record quarterly revenue of $137 million
United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by sales of its cannabidiol medicine Epidiolex in the United States. GW’s total revenue for the third quarter reached $137.1 million, abou…
GW Pharmaceuticals cannabis drug gets regulatory OK in Australia
GW Pharmaceuticals’ plant-derived CBD drug Epidyolex received approval from Australia’s Therapeutic Goods Administration (TGA) to be used in treating seizures related to Lennox-Gastaut syndrome and Dravet syndrome for patients 2 and older. …
DEA loosens rules on prescription CBD drug Epidiolex
Prescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year.
The post DEA loosens rules on prescription CBD drug Epidiolex appeared first on Leafly.